Relapsed and/or Refractory Non-Hodgkin Lymphoma Study
Stopped Study never activated/opened as funding source and other support not available.
Conditions
Interventions
- DRUG: Vorinostat in combination with Bortezomib
Sponsor
The Methodist Hospital Research Institute